Resources for Health Professionals and Patients

Search Details Submited by: "Victor Stanilevskiy "
Number of Items Found: 60

Search Results

Strengthening Health Systems to Improve HIV/AIDS Programs in the E&E Region Using Global Fund Resources
Attached file:	(English, 866.4 kb) EE_HHS_GFATM_Final_0106.pdf
Attached file:	(Russian, 1192.6 kb) EE_HHS_GFATM_Final_0106_rus.pdf
Author(s):	R. Drew , G. Purvis
Description:	Countries in the Europe and Eurasia region are facing a significant and expanding HIV/AIDS epidemic that is largely concentrated among particularly vulnerable populations. A window of opportunity exists to respond effectively to the epidemic and to halt its spread, both within and beyond vulnerable populations. However, available evidence indicates that this opportunity is being missed. One explanation for this is that significant barriers exist within the region’s health systems that prevent rapid scale-up of effective HIV/AIDS programs. This study seeks to examine these barriers and ways they can be overcome. The study was commissioned by the Europe and Eurasia (E&E) Bureau of the U.S. Agency for International Development (USAID). The report focuses on practical steps that can be taken to produce tangible gains for HIV/AIDS programming in the region.
Language:	English, Russian
Publication date:	2005
Primary area(s) of focus:	HIV/AIDS
Pages:	104

Textbook of Pediatric HIV Care
Attached file:	(Russian, 172 kb) Cover
Attached file:	(Russian, 136.6 kb) Table of Contents
Attached file:	(Russian, 788.1 kb) Chapter 1. Normal development and physiology of the immune system
Attached file:	(Russian, 1271.9 kb) Chapter 2. HIV basic virology for clinicians
Attached file:	(Russian, 847.7 kb) Chapter 3. The immunology of pediatric HIV disease
Attached file:	(Russian, 698.7 kb) Chapter 4.The clinical virology of pediatric HIV disease
Attached file:	(Russian, 750.2 kb) Chapter 5.The natural history of pediatric HIV disease
Attached file:	(Russian, 780.7 kb) Chapter 6.The epidemiology of pediatric HIV disease
Attached file:	(Russian, 612.9 kb) Chapter 7.Diagnosis of HIV-1 infection in children
Attached file:	(Russian, 954.4 kb) Chapter 8.Prevention of mother-to-child transmission of HIV
Attached file:	(Russian, 658.1 kb) Chapter 9.Routine pediatric care
Attached file:	(Russian, 463.1 kb) Chapter 10. Immunizations
Attached file:	(Russian, 719.1 kb) Chapter 11.Prevention of opportunistic infections and other infectious complications of HIV in children
Attached file:	(Russian, 678 kb) Chapter 12.Emergency evaluation and care
Attached file:	(Russian, 463 kb) Chapter 13. Adherence to antiretroviral therapy in children and youth
Attached file:	(Russian, 417.8 kb) Chapter 14. Adolescents and HIV
Attached file:	(Russian, 899.3 kb) Chapter 15.Adolescent reproductive health and HIV
Attached file:	(Russian, 843.9 kb) Chapter 16.Growth, nutrition, and metabolism
Attached file:	(Russian, 646.4 kb) Chapter 17. Neurobehavioral function and assessment of children and adolescents with HIV-1 infection
Attached file:	(Russian, 678.5 kb) Chapter 18.Antiretroviral therapy
Attached file:	(Russian, 728.3 kb) Chapter 19.Antiretroviral drug interactions
Attached file:	(Russian, 1169.4 kb) Chapter 21.HIV drug resistance
Attached file:	(Russian, 849.6 kb) Chapter 22.Initiating and changing antiretroviral therapy
Attached file:	(Russian, 578.4 kb) Chapter 26. Neurologic problems
Attached file:	(Russian, 1710.2 kb) Chapter 27. Ophthalmic problems
Attached file:	(Russian, 2942.3 kb) Chapter 31. Pulmonary problems
Attached file:	(Russian, 627.4 kb) Chapter 33. Gastrointestinal disorders
Attached file:	(Russian, 748.1 kb) Chapter 37. Serious infections caused by typical bacteria
Attached file:	(Russian, 539.6 kb) Chapter 38. Tuberculosis
Attached file:	(Russian, 540.5 kb) Chapter 39. DisseminatedMycobacterium avium complex infection
Attached file:	(Russian, 1302.9 kb) Chapter 40. Fungal infections
Attached file:	(Russian, 524.3 kb) Chapter 41. Herpesvirus infections
Attached file:	(Russian, 1480.2 kb) Chapter 42. Pneumocystis carinii pneumonia (PCP)
Attached file:	(Russian, 586.7 kb) Chapter 46. Disclosure
Link to document(s)	http://www.cambridge.org/uk...
Author(s):	S. Zeichner and J. Read
Description:	This comprehensive textbook provides the definitive account of effective care for pediatric HIV patients.
Language:	Russian
Primary area(s) of focus:	HIV/AIDS
Pages:	784

Report on the global AIDS epidemic, 2006
Author(s):	The Joint United Nations Programme on HIV/AIDS
Description:	The UNAIDS 2006 Report on the global AIDS epidemic shows that the AIDS epidemic appears to be slowing down globally, but new infections are continuing to increase in certain regions and countries. The report also shows that important progress has been made in country AIDS responses, including increases in funding and access to treatment, and decreases in HIV prevalence among young people in some countries over the past five years. However AIDS remains an exceptional threat. The response is diverse with some countries doing well on treatment but poorly on HIV prevention efforts and vice-versa. The report indicates that a number of significant challenges remain. Among these are the need for improved planning, sustained leadership and reliable long-term funding for the AIDS response. The English version of the report can be found here The Russian version of the report can be found here
Language:	English, Russian
Primary area(s) of focus:	HIV/AIDS
Pages:	677

Candidiasis and HIV
Attached file:	(Russian, 572.4 kb) Candidiasis and HIV
Link to document(s)	http://hivinsite.ucsf.edu/I...
Author(s):	C. J. Fichtenbaum, J. A. Aberg.
Description:	Mucocutaneous candidiasis occurs in 3 forms in persons with HIV infection: oropharyngeal, esophageal, and vulvovaginal disease. Oropharyngeal candidiasis (OPC) was among the initial manifestations of HIV-induced immunodeficiency to be recognized and typically affects the majority of persons with advanced untreated HIV infection. Presenting months or years before more severe opportunistic illnesses, OPC may be a sentinel event indicating the presence or progression of HIV disease. Although usually not associated with severe morbidity, OPC can be clinically significant. Severe OPC can interfere with the administration of medications and adequate nutritional intake, and may spread to the esophagus. Esophageal candidiasis remains one of the most common opportunistic infections in countries where combination antiretroviral therapy (ART) is a routine part of the standard of care. Vulvovaginal candidiasis is an important concern for women with HIV infection, although the relationship of vulvovaginal candidiasis to HIV infection remains unclear. In resource-poor nations, mucocutaneous candidiasis is a formidable problem. Despite the frequency of mucosal disease, disseminated or invasive infections with Candida and related yeasts are surprisingly uncommon.
Language:	English, Russian
Primary area(s) of focus:	HIV/AIDS, Tuberculosis
Pages:	39

Initiating Antiretroviral Therapy
Attached file:	(Russian, 398.4 kb) Initiating Antiretroviral Therapy
Link to document(s)	http://www.hivinsite.com/In...
Author(s):	E. M. Kojic, C.J. Carpenter
Description:	Combination antiretroviral regimens have revolutionized the treatment of HIV infection, which has resulted in dramatic reductions in morbidity, mortality, and health care utilization. Effective antiretroviral therapy (ART) consistently results in sustained suppression of HIV-1 RNA replication, resulting in gradual increases in CD4 T-lymphocyte count, sometimes to normal levels. ART does not eradicate the virus, as viral replication continues in lymphoid tissue despite suppressive treatment. However, durable suppression of viral replication and the accompanying increases in CD4 count, reverse HIV disease progression, even in persons with advanced HIV infection. It is now possible to achieve at least transient reversal of disease progression in almost all patients who have received no prior ART, as HIV strains present in these "treatment-naive" patients will be susceptible to available antiretroviral drugs.
Language:	English, Russian
Primary area(s) of focus:	HIV/AIDS

Aspergillosis and HIV
Attached file:	(Russian, 419.5 kb) Aspergillosis and HIV
Link to document(s)	http://www.hivinsite.com/In...
Author(s):	A. Sturt,, J. A. Aberg
Description:	Exposure to Aspergillus is universal, but aspergillosis is uncommon unless drugs, infection, or malignancy have altered the host immune defenses. The disease usually occurs in transplant recipients or in patients with hematologic malignancies, when phagocytic host defenses by granulocytes and macrophages are quantitatively or functionally suppressed.
Language:	English, Russian
Primary area(s) of focus:	HIV/AIDS
Pages:	14

Immunopathogenesis of HIV Infection
Attached file:	(Russian, 539.4 kb) Immunopathogenesis of HIV Infection
Link to document(s)	http://www.hivinsite.com/In...
Author(s):	M. M. Lederman, B. Rodriguez, S. Sieg.
Description:	As intracellular parasites, all viruses must be intimately familiar with host cellular machinery and capable of suborning it to support their replication cycle. For HIV, this relationship is particularly complex and intimate because HIV targets, infects, and incapacitates cells central to antimicrobial defenses. Thus, host immune defenses and HIV pathogenesis are inextricably linked. Whereas this parasitic relationship may contribute to the persistence and progression of HIV infection, careful study of the relationship between HIV and the immune system has also yielded important insights into mechanisms of immune homeostasis and host defenses in general. This chapter will examine briefly the proposed mechanisms whereby HIV infects host immune cells, the mechanisms whereby host defenses are mobilized to attenuate HIV replication, the strategies HIV uses to evade host immune responses, and finally, the mechanisms whereby HIV induces immune deficiency that places persons at risk for the opportunistic infections and malignancies that define AIDS.
Language:	English, Russian
Primary area(s) of focus:	HIV/AIDS
Pages:	38

Adherence to HIV Antiretroviral Therapy
Attached file:	(Russian, 699.3 kb) Adherence to HIV Antiretroviral Therapy
Link to document(s)	http://www.hivinsite.com/In...
Author(s):	E. L. Machtinger, D. R. Bangsberg.
Description:	In countries with broad access to effective antiretroviral therapy (ART), the clinical benefits have been dramatic. Far fewer people are progressing to AIDS, hospital AIDS wards have practically emptied, and the age-adjusted death rate from HIV/AIDS has declined by more than 70%.Adherence to ART has emerged as both the major determinant and the Achilles' heel of this success. Antiretroviral adherence is the second strongest predictor of progression to AIDS and death, after CD4 count. Incomplete adherence to ART, however, is common in all groups of treated individuals. The average rate of adherence to ART is approximately 70%, despite the fact that long-term viral suppression requires near-perfect adherence. The resulting virologic failure diminishes the potential for long-term clinical success. Drug-resistant strains of HIV selected through ongoing replication in the presence of ART also can be transmitted to uninfected or drug-naive patients, leaving them with fewer treatment options.Nonadherence may eventually undermine the dramatic improvements in HIV-related health parameters seen in resource-rich countries and expected in developing countries as ART becomes more widely available.
Language:	English, Russian
Primary area(s) of focus:	HIV/AIDS
Pages:	52

test 1-2
Attached file:	(Albanian, 5.1 kb) Bill.xls
Link to document(s)	http://www.google.com
Description:	This is a test

Clinical Characteristics of Kaposi Sarcoma
Attached file:	(Russian, 434.2 kb) Clinical Characteristics of Kaposi Sarcoma
Link to document(s)	http://www.hivinsite.com/In...
Author(s):	Krown S. E.
Description:	Kaposi sarcoma (KS) was one of the first conditions recognized as an opportunistic sequela of HIV infection, and remains the most common AIDS-associated neoplasm. AIDS-associated KS occurs with increased frequency in all HIV transmission groups compared with the general population, but at a particularly high rate among men who have sex with men (MSM). The epidemiology of AIDS-associated KS has long suggested that an environmental or infectious sexually transmitted cofactor might contribute to the development of KS. The search for such a cofactor led, in 1994, to the discovery of a novel herpesvirus, human herpesvirus-8 (HHV-8), also known as the Kaposi sarcoma-associated herpesvirus (KSHV). HHV-8/KSHV is found in all forms of KS, and infection with the virus appears to be necessary but not sufficient for KS to develop. Other factors believed to be involved in the development of AIDS-associated KS include altered expression and response to growth factors and cytokines, and modulation of KS growth by an HIV gene product, the Tat protein. AIDS-associated KS varies in its presentation from an indolent process with minimal clinical consequences to a disseminated, aggressive disease.
Language:	Russian
Primary area(s) of focus:	HIV/AIDS
Pages:	18

Results Page:

1 2 3 4 5 6

Contribute a New Resource

Discussion Forum

EurasiaHealth Knowledge Network

Resources for Health Professionals and Patients